2017
DOI: 10.1016/j.cyto.2016.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-1β as a driver of renal NGAL production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 46 publications
1
11
0
Order By: Relevance
“…It is also interesting to note that the identified immunological markers interact with each other during urological infection by restricting bacterial growth and mediating trans-epithelial movement of neutrophils 36 . IL-1β induces renal production of NGAL in mice model experiments 37 , and NGAL modulates MMP9 activity by protecting it from degradation 38 . MMP-9, NGAL and some interleukins, have been previously studied as potential biomarkers for UTI, particularly in infants and children, however, conclusions were contradictory 39–44 .…”
Section: Discussionmentioning
confidence: 99%
“…It is also interesting to note that the identified immunological markers interact with each other during urological infection by restricting bacterial growth and mediating trans-epithelial movement of neutrophils 36 . IL-1β induces renal production of NGAL in mice model experiments 37 , and NGAL modulates MMP9 activity by protecting it from degradation 38 . MMP-9, NGAL and some interleukins, have been previously studied as potential biomarkers for UTI, particularly in infants and children, however, conclusions were contradictory 39–44 .…”
Section: Discussionmentioning
confidence: 99%
“… 16 IL-1β was found to upregulate NGAL in human epithelial cells 16 and to possibly comprise a determinant for circulating NGAL in systemic inflammations. 17 A study found IL-10 overexpression by primary macrophages to enhance their pro-resolution activity in complex inflammation-associated pathologies. 18 Likewise, blocking of NGAL production in macrophages reduced IL-10 protective effects in a kidney ischemia/reperfusion injury model, substantiating NGAL-associated pro-proliferative and anti-inflammatory properties.…”
Section: Introductionmentioning
confidence: 99%
“…Both cell lines were cultured in DMEM-High Glucose (EuroClone) (17.5 mM glucose) with 10% fetal bovine serum (Biochrom AG), l -glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 μg/ml) at 37 °C in a humidified atmosphere with 5% CO 2 . After reaching a confluence of about 80%, serum was removed for 24 h (starvation) and subsequently treated with TGF-β (10 ng/ml) or IL-1β (10 ng/ml) [41, 42] in the presence or absence of Canakinumab (5 μg/ml).…”
Section: Methodsmentioning
confidence: 99%